Searchable abstracts of presentations at key conferences in endocrinology

ea0081ep84 | Adrenal and Cardiovascular Endocrinology | ECE2022

The primary aldosteronism rollercoaster: hypoaldosteronism as a potential postoperative complication

Palma August , Hu Lihua , Cheow Heok , Mendichovszky Iosif , Kosmoliaptsis Vasilis , Marker Alison , Bashari Waiel , Senanayake Russell , Gurnell Mark

Introduction: Primary aldosteronism (PA) is a common and potentially reversible cause of secondary hypertension, characterised by resistance to standard antihypertensive therapy and possible hypokalaemia. Lateralisation investigations, including adrenal vein sampling (AVS), are required to distinguish between unilateral or bilateral disease, with unilateral disease representing a potentially surgically curable form of PA. The majority of patients proceeding to adrenalectomy re...

ea0081p263 | Adrenal and Cardiovascular Endocrinology | ECE2022

Development of a novel treatment strategy which involves thermal ablation of adrenal adenomas using electromagnetic energy

Farnan Richard , Bottiglieri Anna , Farina Laura , Senanayake Russell , Gurnell Mark , Prakash Punit , O'Halloran Martin , Cappiello Grazia , Newell Caoimhe , Keating Muireann , Rahmani George , Conall Dennedy Michael

Primary aldosteronism (PA) arises from one or both adrenal glands and is a common cause of secondary hypertension accounting for approximately 5-12% of all hypertension. Current therapy involves mineralocorticoid receptor antagonists for bilateral disease (60%) or adrenalectomy for unilateral disease (30%). We investigate treatment planning of percutaneous adrenal ablation as an alternative definitive therapeutic modality for unilateral and bilateral disease. The main objectiv...